secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0001493152-23-037299
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharmaceuticals furnishes October 2023 investor presentation; content not provided in filing excerpt
--------------------------------------------------------------------------------

- Slide presentation published to company website as of Oct. 16, 2023.
- Presentation speaks as of the filing date; company disclaims obligation to update.
- No specific financial or clinical data from the presentation available in this extract.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223037299/0001493152-23-037299-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223037299/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037299

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer